Long Term Study to Evaluate the Safety and Tolerability of Oxcarbazepine Extended Release (OXC XR) as Adjunctive Therapy in Pediatric Subjects With Refractory Partial Epilepsy

This study is enrolling participants by invitation only.

Study NCT00918424 Information provided by Supernus Pharmaceuticals, Inc.

First Received: June 9, 2009 Last Updated: November 11, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is enrolling participants by invitation only.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given